MaxBiotic 4B

by Karuna · tablet or pill · 100 tablets

  • On the market (NIH)
  • UPC 0 18647 03111 0
  • DSLD label 35818
  • Serving 1 tablet
  • 100 servings

MaxBiotic 4B by Karuna lists 6 ingredients; 6 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on July 25, 2014.

What is in MaxBiotic 4B?

Each row as the label prints it, per serving of 1 tablet. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

MaxBiotic 4B: Supplement Facts rows against the market (DSLD label 35818, January 2026 release)
IngredientAmount% DVAmong products listing it
MaxBiotic Proprietary BlendMaxBiotic Proprietary Blend Note: at time of manufacture4,000,000,000 organisms
Lactobacillus acidophilusin the blend, no amount given
Bifidobacterium bifidumin the blend, no amount given
Lactobacillus plantarumin the blend, no amount given
Lactobacillus rhamnosusin the blend, no amount given
Lactobacillus helveticusin the blend, no amount given
Streptococcus thermophilusin the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 35818 (entered July 25, 2014), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 6 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with MaxBiotic 4B's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested use for adults: 1 tablet daily, or as directed by your health care practitioner.
Allergens and what it does not contain
This product contains no yeast, wheat, soy, corn, milk, sugar, artificial coloring, preservatives or flavoring.
Storage
Refrigerate after opening.

Source: label statements in DSLD label 35818.

What else is on the label?

Other ingredients: Microcrystalline Cellulose, Hydroxypropyl Methylcellulose, Pectin, Sodium Bicarbonate, {Sodium} Carbonate, Silica Dioxide, Stearate, Guar Gum, Turmeric.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): KARUNA(R) RESPONSIBLE NUTRITION(TM); Extended Shelf-Life Live-Bac(R) Process; Acid-Bypass BIO-tract(TM) System.

How many labels does MaxBiotic 4B have?

One label is on file, entered on July 25, 2014.

  1. Label 35818 (current) Entered July 25, 2014 · on the market · 100 tablets · UPC 0 18647 03111 0

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Karuna Corporation (manufacturer), Novato, CA. All Karuna products.

Where next?